Connect with us

Subscribe

biotech

Game-changing cancer therapy

3D pancreas cancer illustration. Credit: AdobeStock

LONDON – A potentially breakthrough cancer killing treatment being developed by LIfT BioSciences is attracting major new investment.

Investors including Johnston Milner, a renowned biotech ‘super-angel’, Kizoo Technology Ventures and Downing Ventures are helping LIfT in its quest to pioneer the first curative and affordable cell therapy for all solid tumours.

“LIfT has developed and patented the most promising cancer therapy I have come across to date,” said Jonathan Milner.

Alex Blyth, CEO of LIfT BioSciences believes N-LIfT, the company’s first product, has the potential to generate a ‘paradigm-shifting change in how we treat cancer’.

“Rapidly dividing cancer cells are able to adapt whereas targeted therapies are not,” he explains. “This is a major flaw with current treatment options for patients, as their cancers are often only temporarily slowed before mutating and returning aggressively. Until now the only other approach has been broad chemotherapies that are essentially only slightly more toxic to cancer cells than healthy cells. Whereas N-LIfT is a smart living therapy that selectively destroys any cancer cell we throw at it, regardless of type, mutational status or whether they are hot or cold tumours. N-LIfT also has the potential to improve the performance of other therapies that struggle with solid tumours and cold (non-inflamed) tumour environments.”

LIfT BioSciences will now invest in further developing its manufacturing technology to produce N-LIfT. The company said it is looking to demonstrate in-vivo superiority over standard of care in Pancreatic Ductal Adenocarcinoma (PDAC), Non-Small Cell Lung Cancer (NSCLC) and Hepatocellular Carcinoma (HCC). Venture capitalists and private family wealth funds are invited to join the investment syndicate, to help fund early clinical trials.

Newsletter Signup

Written By

Iain is a writer, journalist and lecturer, and former editor of two international business magazines. Iain is now editor of Innovators Magazine, as well as the strategic content director for OnePoint5Media.

Advertisement

New platform for Japanese innovators advancing the Global Goals

Editor's Picks

Win signed new copy of ‘A Child in Berlin’

creativity

Sign up for new season of the Inside Ideas podcast

Editor's Picks

A new masterclass in resilience from girl who survived Hitler’s Berlin

creativity

Connect
Newsletter Signup